ACRES Endorses MAGI CTA Template
The contract negotiation process is generally believed to be the primary bottleneck in site startup and MAGI's CTA template would help that process.
The Alliance for Clinical Research Excellence and Safety (ACRES) has endorsed the standard clinical trial agreement (CTA) template created by Model Agreements & Guidelines International (MAGI).
The contract negotiation process is generally believed to be the primary bottleneck in site startup. In 2004, MAGI initiated a collaborative effort to create a CTA template that would be widely accepted.
MAGI joins a growing list of nearly 200 organizations and individuals that are teaming up with ACRES to improve the safety, quality, transparency and cost-effectiveness of the clinical research.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Full Phase IIIb BATURA Trial Results Show Airsupra Cuts Severe Exacerbations by 47% in Mild Asthma
May 20th 2025Results from the pivotal BATURA trial show that Airsupra (albuterol/budesonide) significantly outperformed albuterol monotherapy in reducing severe asthma exacerbations and systemic corticosteroid exposure, reinforcing its role as a next-generation, anti-inflammatory rescue therapy for mild asthma patients.
